Obstetrics & gynaecology

Elagolix reduces menstrual bleeding from most common uterine tumors

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States—benign tumors that disproportionately affect African-Americans, an international clinical trial ...

page 7 from 22